• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Enforcement Report for Week of June 28, 2023

    FDA

    The Harvard Drug Group, LLC Issues Voluntary Nationwide Recall of Dronabinol Capsules, USP, 2.5 mg and Ziprasidone Hydrochloride Capsules, 20 mg Due to Label Mix-up

    FDA

    Zydus Pharm’s Generic Ziprasidone Hydrochloride Receives Approval In US

    FDA

    Aurobindo`s Generic Ziprasidone Hydrochloride Receives Approval In US

    FDA

    US FDA warns Pfizer antipsychotic linked to serious allergic reaction

    REUTERS

    FDA Drug Safety Communication: FDA Reporting Mental Health Drug Ziprasidone (Geodon) Associated with Rare but Potentially Fatal Skin Reactions

    EIN NEWSDESK

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.